[Form 4] Wendy's Co Insider Trading Activity

Rhea-AI Filing Summary

The Wendy's Company reported a Form 4 transaction for its U.S. Chief Marketing Officer, identified as an officer of the company. On 12/15/2025, she received multiple grants of restricted stock units (RSUs) with tandem dividend equivalent and tax withholding rights, each RSU representing a right to receive one share of common stock at no cash cost.

The new RSUs reflect dividend equivalent units added to several existing equity awards, in amounts including 11, 147, 35, 89, 532, 179 and 896 units, all settled in common stock. After these transactions, she beneficially owned 112,956 derivative securities tied to Wendy's common stock.

The RSUs have staggered vesting schedules between August 2026 and August 2028, with various awards vesting in one or more installments and all vesting remaining subject to Ms. Radkoski’s continued employment with the company on the applicable vesting dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Radkoski Lindsay J.

(Last) (First) (Middle)

C/O THE WENDY'S COMPANY

ONE DAVE THOMAS BLVD.

(Street)

DUBLIN OH 43017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Wendy's Co [ WEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CMO, U.S.

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	(2)	12/15/2025		A		11(3)		(4)	(4)	Common Stock	11	$0	111,078	D
Restricted Stock Units(1)	(2)	12/15/2025		A		147(3)		(5)	(5)	Common Stock	147	$0	111,225	D
Restricted Stock Units(1)	(2)	12/15/2025		A		35(3)		(6)	(6)	Common Stock	35	$0	111,260	D
Restricted Stock Units(1)	(2)	12/15/2025		A		89(3)		(7)	(7)	Common Stock	89	$0	111,349	D
Restricted Stock Units(1)	(2)	12/15/2025		A		532(3)		(8)	(8)	Common Stock	532	$0	111,881	D
Restricted Stock Units(1)	(2)	12/15/2025		A		179(3)		(9)	(9)	Common Stock	179	$0	112,060	D
Restricted Stock Units(1)	(2)	12/15/2025		A		896(3)		(10)	(10)	Common Stock	896	$0	112,956	D

Explanation of Responses:

1. With tandem dividend equivalent rights and tax withholding rights.

2. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

3. Represents dividend equivalent units issued on December 15, 2025.

4. The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

5. The restricted stock units will vest in full on December 7, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

6. The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

7. The restricted stock units will vest in two remaining equal installments on August 15, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

8. The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date.

9. The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

10. The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date.

	/s/ Mark L. Johnson, Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.